Profil
Mikko Lauri Sampsa Mannerkoski is the founder of Aventum Partners Oy, founded in 2003.
Mr. Mannerkoski was the founder of Rappta Therapeutics Oy, founded in 2019, and held the title Chief Executive Officer & Director.
Mr. Mannerkoski is the founder of Aventum Oy, founded in 2003, and holds the title Partner.
Mr. Mannerkoski currently works at Mandatum & Co. Oy as Deputy Managing Director since 1997.
Postes actifs de Mikko Lauri Sampsa Mannerkoski
| Sociétés | Poste | Début |
|---|---|---|
Mandatum & Co. Oy
Mandatum & Co. Oy Life/Health InsuranceFinance Provides investment advice for insurance company portfolio | Corporate Officer/Principal | 14/09/2010 |
Aventum Oy
Aventum Oy Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Fondateur | 29/08/2003 |
Anciens postes connus de Mikko Lauri Sampsa Mannerkoski
| Sociétés | Poste | Fin |
|---|---|---|
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Operates as biopharmaceutical company that develops anti-cancer molecular glues | Directeur Général | 15/09/2021 |
Aventum Partners Oy
Aventum Partners Oy Investment ManagersFinance Provides financial advisory services | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Aventum Partners Oy
Aventum Partners Oy Investment ManagersFinance Provides financial advisory services | Finance |
Aventum Oy
Aventum Oy Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Mandatum & Co. Oy
Mandatum & Co. Oy Life/Health InsuranceFinance Provides investment advice for insurance company portfolio | Finance |
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Operates as biopharmaceutical company that develops anti-cancer molecular glues | Health Technology |
















